What is the recommended taper schedule for individuals taking Adderall (amphetamine and dextroamphetamine) for less than a year?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall Tapering Schedule for Individuals Taking It Less Than One Year

For individuals taking Adderall for less than one year, a taper schedule of approximately 10% of the original dose per week is recommended to minimize withdrawal symptoms and ensure patient safety. 1

Recommended Tapering Approach

Initial Assessment

  • Calculate the patient's total daily Adderall intake
  • Maintain the same dosing frequency during the taper
  • Assess for any comorbid conditions that may complicate tapering (anxiety, depression)

Tapering Schedule

  1. First Phase (Weeks 1-4)

    • Decrease dose by 10% of the original dose per week
    • Example: For a patient taking 20mg daily
      • Week 1: 18mg daily
      • Week 2: 16mg daily
      • Week 3: 14mg daily
      • Week 4: 12mg daily
  2. Middle Phase (Weeks 5-8)

    • Continue 10% reductions of original dose
    • Slow to 5% reductions if withdrawal symptoms become problematic
    • Monitor closely for withdrawal symptoms
  3. Final Phase (Weeks 9+)

    • When reaching the smallest available dose unit, extend the interval between doses
    • Example: From daily dosing to every other day, then every third day
    • Discontinue when medication is taken less frequently than once daily 1

Monitoring and Follow-up

  • Follow up at least weekly during active tapering 1
  • Assess for withdrawal symptoms at each visit:
    • Fatigue, increased appetite, sleep disturbances
    • Irritability, anxiety, depression
    • Difficulty concentrating

Management of Withdrawal Symptoms

  • Non-pharmacological approaches:

    • Cognitive behavioral therapy
    • Regular exercise
    • Sleep hygiene practices
    • Stress management techniques 1
  • Pharmacological management for specific symptoms:

    Symptom Management
    Sympathetic hyperactivity Clonidine 0.1-0.2mg orally every 6 hours 2
    Insomnia Trazodone or hydroxyzine as needed
    Anxiety Hydroxyzine or short-term use of non-benzodiazepine anxiolytics
    Pain NSAIDs or acetaminophen

Common Pitfalls to Avoid

  • Tapering too rapidly: This increases withdrawal symptoms and reduces success rates 1
  • Mistaking withdrawal for ADHD symptom return: Withdrawal symptoms can mimic ADHD symptoms
  • Abrupt discontinuation: Significantly increases risk of severe withdrawal symptoms 2
  • Inadequate monitoring: Follow-up less than weekly during active tapering can lead to poor outcomes 1

Special Considerations

  • If withdrawal symptoms become severe, pause the taper temporarily and resume at a slower rate 2
  • For patients with significant anxiety about the taper, consider starting with smaller reductions (5% instead of 10%)
  • Avoid tapering during high-stress periods (major life events, exams)
  • Consider consulting with an addiction specialist if withdrawal symptoms are difficult to manage 2

The CDC and Mayo Clinic guidelines emphasize that shorter-term users (<1 year) can typically tolerate a faster taper than long-term users, who may require tapers extending over months 2, 1. However, even for shorter-term users, individualization of the taper rate based on withdrawal symptoms is essential for success.

References

Guideline

Tapering Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.